Up 23% in the past year. Is it too late to buy this ASX 200 insurance share?

Brokers are tipping as much as 18% upside for this ASX 200 insurance stock.

| More on:
Woman using laptop for job search

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The QBE share price has been on a roll lately, peaking at a near-10-year high of $15.64 today
  • The stock rocketed on the back of its latest earnings release, wherein it tipped growth to continue this financial year
  • Many top brokers remain bullish on QBE, with one tipping it to soar to $18

The share price of S&P/ASX 200 Index (ASX: XJO) giant QBE Insurance Group Ltd (ASX: QBE) leapt to long-forgotten heights on Monday. The stock peaked at a near-decade high of $15.64 earlier today.

Unfortunately, the QBE share price has since slumped to trade at $15.31 this afternoon. That's 0.26% lower than its previous close.

So, what might the future hold for the ASX 200 insurance share? Let's take a look.

Is this ASX 200 insurance share still in the buy zone?

The QBE share price has been on a roll lately, with the most recent news from the company being its financial year 2022 earnings, released in February.

The insurance provider posted a combined operating ratio (COR) of 93.7% – an improvement on the prior year's 95% COR. Meanwhile, it posted a 13% growth in gross written premium (GWP).

Looking forward, the company expects further improvement, with its financial year 2023 Plan Group COR guidance sitting at around 93.5% and its GWP growth tipped to be in the mid-to-high single digits.

Not to mention, its investment portfolio has seen improvements on the back of interest rate hikes, while its premiums have largely been lifted in line with inflation.

All that means the company could have the potential to thrive in the current environment.

And the ASX 200 insurance provider isn't the only one that's hopeful of its future – many experts are bullish on its shares.

What do experts say?

Brokers and experts broadly appear hopeful for the QBE share price.

UBS, Goldman Sachs, and Morgans all have buy ratings on the stock, with respective price targets of $18, $17.45, and $16.98. That represents between 11% and 18% of potential upside.

Morgans thinks the share is cheap right now. It also expects benefits from rate hikes are yet to be felt in the ASX 200 company's insurance book, my Fool colleague James Mickleboro reports.

UBS, meanwhile, expects strong premium prices to bolster the QBE's bottom line.

Speaking of, Goldman Sachs notes the company's well-capitalised balance sheet could bode well in the current uncertain economic environment.

Finally, Airlie senior investment analyst Joe Wright is also bullish, as The Motley Fool Australia's Tony Yoo reports. Wright recently wrote for the fund manager's blog:

We continue to believe QBE is underearning as margins for both the North American business unit, and more recently the Lloyd's syndicates, have dragged on group performance.

QBE share price snapshot

The QBE share price has been on a roll lately – the ASX 200 insurance stock has soared 23% over the last 12 months. It's also gained 17% since the start of 2023.

Meanwhile, the ASX 200 has risen 5% year to date and 2% since this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Financial Shares

Stressed, unhappy and tired scientist with a headache working on a computer in a lab. Worried, anxious and frustrated pathologist, researcher and doctor struggling with burnout, tension and strain.
Financial Shares

Are Medibank shares a bargain buy after being sold off?

Could this be the time to pounce?

Read more »

Man looks confused as he works at his laptop. watching the Magnis share price movements
Financial Shares

Down 21% this year, are NIB shares a buy?

Could this be the turning point?

Read more »

Man smiling at a laptop because of a rising share price.
Financial Shares

AMP share price lifts 8% in October amid improved cashflows

Investors were impressed with AMP's third-quarter report.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Share Market News

This ASX All Ords stock is down 37%, and one insider just bought up over $500,000 worth

This company director just raised his stake by 1,735%.

Read more »

A young boy reaches up to touch the raindrops on his umbrella, as the sun comes out in the sky behind him.
Financial Shares

IAG share price lifts amid AGM and FY25 guidance

The insurance giant held its annual general meeting today.

Read more »

Delighted adult man, working on a company slogan, on his laptop.
Financial Shares

Top Australian financial stocks to buy now

These companies are well-positioned to grow, brokers say.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Financial Shares

$25 billion ASX 200 stock falls on ASIC probe

This blue chip is facing civil penalties, declarations and adverse publicity orders.

Read more »

Man pointing at a blue rising share price graph.
Financial Shares

Up 119% in a year, here's why this ASX financial stock is rocketing again on Tuesday

Investors are optimistic about the outlook for this soaring ASX financial stock.

Read more »